Valuation: IDEXX Laboratories, Inc.

Capitalization 36.77B 35.33B 33.27B 29.25B 52.31B 3,196B 57.98B 395B 148B 1,335B 138B 135B 5,575B P/E ratio 2024
38.7x
P/E ratio 2025 * 37.6x
Enterprise value 37.23B 35.77B 33.69B 29.61B 52.95B 3,235B 58.69B 400B 149B 1,351B 140B 137B 5,644B EV / Sales 2024
8.83x
EV / Sales 2025 * 9.13x
Free-Float
75.42%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.43%
1 week-1.39%
Current month+6.86%
1 month+5.54%
3 months+8.32%
6 months-9.26%
Current year+9.08%
More quotes
1 week
440.99
Extreme 440.99
463.63
1 month
405.84
Extreme 405.84
474.67
Current year
405.84
Extreme 405.84
474.67
1 year
398.50
Extreme 398.5
583.39
3 years
317.06
Extreme 317.06
583.39
5 years
168.65
Extreme 168.65
706.95
10 years
61.37
Extreme 61.37
706.95
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 28/06/2019
Director of Finance/CFO 62 03/01/2014
Chief Tech/Sci/R&D Officer 57 01/08/2021
Director TitleAgeSince
Director/Board Member 74 16/07/2012
Director/Board Member 64 23/10/2019
Director/Board Member 63 15/07/2013
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+0.43%-1.39%-18.18%-7.71% 36.77B
Average +0.43%-3.17%-18.18%-7.71% 36.77B
Weighted average by Cap. +0.43%-3.17%-18.18%-7.71%
See all sector performances

Financials

2024 2025 *
Net sales 3.88B 3.73B 3.51B 3.09B 5.52B 337B 6.12B 41.76B 15.59B 141B 14.56B 14.26B 589B 4.12B 3.96B 3.73B 3.28B 5.86B 358B 6.5B 44.33B 16.54B 150B 15.45B 15.14B 625B
Net income 875M 841M 792M 696M 1.24B 76.05B 1.38B 9.41B 3.51B 31.76B 3.28B 3.21B 133B 969M 931M 877M 770M 1.38B 84.18B 1.53B 10.42B 3.89B 35.16B 3.63B 3.56B 147B
Net Debt 455M 437M 412M 362M 647M 39.53B 717M 4.89B 1.83B 16.51B 1.71B 1.67B 68.97B 866M 832M 784M 689M 1.23B 75.29B 1.37B 9.32B 3.48B 31.45B 3.25B 3.18B 131B
More financial data * Estimated data
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Employees
11,000
More about the company
Date Price Change Volume
20/02/25 450.99 $ +0.43% 499,941
18/02/25 449.06 $ +1.02% 632,108
14/02/25 444.53 $ -3.31% 553,759
13/02/25 459.76 $ +0.53% 601,108
12/02/25 457.35 $ -1.38% 634,043

Delayed Quote Nasdaq, 20 February 2025 at 08:00 am AEDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
449.06USD
Average target price
501.62USD
Spread / Average Target
+11.71%
Consensus

Quarterly revenue - Rate of surprise